Sagefield Capital’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Sagefield Capital’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,600	Closed	-$823K	–	106
2023 Q4	$823K	Buy	+2,600	New	+$505K	0.11%	77

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Sagefield Capital's KRTX Position: Q1 2024 in Review

Sagefield Capital sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,600 shares — an estimated $823K sold.

Sagefield Capital first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $823K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Sagefield Capital reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Sagefield Capital sold 2,600 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $823K.
Sagefield Capital first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Sagefield Capital's Karuna Therapeutics, Inc. Common Stock position peaked at $823K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Sagefield Capital's 13F filing for Q1 2024, filed 15 May 2024.